Role of Famotidine in the Clinical Improvement of COVID-19 Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

208

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

April 15, 2021

Study Completion Date

April 15, 2021

Conditions
Covid19
Interventions
DRUG

Famotidine 20 MG

Famotidine; tablet Famotac 20mg oral form.

Trial Locations (2)

4000

Chattogram General Hospital, Chittagong

Unknown

M. Abdur Rahim Medical College Hospital, Dinājpur

All Listed Sponsors
collaborator

M Abdur Rahim Medical College and Hospital

OTHER_GOV

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

lead

Chattogram General Hospital

OTHER_GOV

NCT04504240 - Role of Famotidine in the Clinical Improvement of COVID-19 Patients. | Biotech Hunter | Biotech Hunter